HUGHES INST has a total of 12 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are SUZHOU XINNUOWEI PHARMACEUTICAL TECH CO LTD, SELVITA SA and HANDFORTH INVEST LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Special acyclic compounds | |
#5 | Peptides | |
#6 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Uckun Fatih M | 11 |
#2 | Malaviya Ravi | 2 |
#3 | Liu Xing-Ping | 2 |
#4 | Narla Rama Krishna | 2 |
#5 | Venkatachalam Taracad K | 2 |
#6 | Sudbeck Elise A | 2 |
#7 | Navara Christopher S | 2 |
#8 | Malavia Ravi | 1 |
#9 | D Cruz Osmond J | 1 |
#10 | Ventatachalam Taracad K | 1 |
Publication | Filing date | Title |
---|---|---|
US6537766B1 | Ikaros isoforms and mutants | |
AU5682599A | Vanadium compounds for treating cancer | |
WO0035930A1 | Vanadium compounds for treating cancer | |
US6124324A | Thiophene-ethyl thiourea compounds and use | |
US6066640A | Hydroxy-halo-quinazolines for augmentation of mast cell bactericidal activity | |
US6080747A | JAK-3 inhibitors for treating allergic disorders | |
US6136335A | Phenethyl-5-bromopyridylthiourea (PBT) and dihydroalkoxybenzyloxopyrimidine (DABO) derivatives exhibiting spermicidal activity | |
US6150540A | Versatile intermediate for annonaceous acetogenins | |
US6172071B1 | Lipid-lowering quinazoline derivative | |
US5998411A | Heterocyclic nonnucleoside inhibitors of reverse transcriptase |